New
Service for TodaysSeniorsNetwork.com
readers...roll mouse over, click on
highlighted links in stories to review items
from Amazon
Now, keep up to date
with daily feeds of newly posted stories
about America's Seniors...click on the box
to the left
Air
pollution may cause Heart Disease; Nano-sized
particles most damaging
Newswise — Patients prone to heart disease
may one day be told by physicians to avoid
not only fatty foods and smoking but air
pollution too.
A new academic study led by UCLA researchers
has revealed that the smallest particles
from vehicle emissions may be the most
damaging components of air pollution in
triggering plaque buildup in the arteries,
which can lead to heart attack and stroke.
The findings appear in the Jan. 17 online
edition of the journal Circulation Research.
The scientists identified a way in which
pollutant particles may promote hardening of
the arteries — by inactivating the
protective qualities of high density
lipoprotein (HDL) cholesterol, known as
"good" cholesterol.
A multicampus team from UCLA, the University
of Southern California, the University of
California, Irvine, and Michigan State
University contributed to the research,
which was led by Dr. Andre Nel, UCLA's chief
of nanomedicine. The study was primarily
funded by the National Institute of
Environmental Health Sciences and the U.S.
Environmental Protection Agency (EPA).
"It appears that the smallest air pollutant
particles, which are the most abundant in an
urban environment, are the most toxic," said
first author Dr. Jesus Araujo, assistant
professor of medicine and director of
environmental cardiology at the David Geffen
School of Medicine at UCLA.
"This is the first study that demonstrates
the ability of nano-sized air pollutants to
promote atherosclerosis in an animal model."
Nanoparticles are the size of a virus or
molecule — less than 0.18 micrometers, or
about one-thousandth the size of a human
hair. The EPA currently regulates fine
particles, which are the next size up, at
2.5 micrometers, but doesn't monitor
particles in the nano or ultrafine range.
These particles are too small to capture in
a filter, so new technology must be
developed to track their contribution to
adverse health effects.
"We hope our findings offer insight into the
impact of nano-sized air pollutant particles
and help explore ways for stricter air
quality regulatory guidelines," said Nel,
principal investigator and a researcher at
UCLA's California NanoSystems Institute.
Nel added that the consequences of air
pollution on cardiovascular health may be
similar to the hazards of secondhand smoke.
Pollution particles emitted by vehicles and
other combustion sources contain a high
concentration of organic chemicals that
could be released deep into the lungs or
even spill over into the systemic
circulation.
The UCLA research team previously reported
that diesel exhaust particles interact with
artery-clogging fats in low-density
lipoprotein (LDL) cholesterol to activate
genes that cause the blood-vessel
inflammation that can lead to heart disease.
In the current study, researchers exposed
mice with high cholesterol to one of two
sizes of air pollutant particles from
downtown Los Angeles freeway emissions and
compared them with mice that received
filtered air that contained very few
particles.
The study, conducted over a five-week
period, required a complex exposure design
that was developed by teams led by Dr.
Michael Kleinman, professor of community and
environmental medicine at UC Irvine, and Dr.
Constantinos Sioutas, professor of civil and
environmental engineering at USC.
Researchers found that mice exposed to
ultrafine particles exhibited 55 percent
greater atherosclerotic-plaque development
than animals breathing filtered air and 25
percent greater plaque development than mice
exposed to fine-sized particles.
"This suggests that ultrafine particles are
the more toxic air pollutants in promoting
events leading to cardiovascular disease,"
Araujo said.
Pollutant particles are coated in chemicals
sensitive to free radicals, which cause the
cell and tissue damage known as oxidation.
Oxidation leads to the inflammation that
causes clogged arteries. Samples from
polluted air revealed that ultrafine
particles have a larger concentration of
these chemicals and a larger surface area
where these chemicals thrive, compared with
larger particles, Sioutas noted.
"Ultrafine particles may deliver a much
higher effective dose of injurious
components, compared with larger pollutant
particles," Nel said.
Scientists also identified a key mechanism
behind how these air pollutants are able to
affect the atherosclerotic process. Using a
test developed by Dr. Mohamad Navab, study
co-author and a UCLA professor of medicine,
researchers found that exposure to air
pollutant particles reduced the
anti-inflammatory protective properties of
HDL cholesterol.
"HDL normally helps reduce the vascular
inflammation that is part of the
atherosclerotic process," said Dr. Jake
Lusis, study co-author and a UCLA professor
of cardiology, human genetics and
microbiology, immunology and molecular
genetics. "Surprisingly, we found that
exposure to air pollutant particles, and
especially the ultrafine size, significantly
decreased the positive effects of HDL."
To explore if air particle exposure caused
oxidative stress throughout the body — which
is an early process triggering the
inflammation that causes clogged arteries —
researchers checked for an increase in genes
that would have been activated to combat
this inflammatory progression.
"We found greater levels of gene activation
in mice exposed to ultrafine particles,
compared to the other groups," Lusis said.
"Our next step will be to develop a
biomarker that could enable physicians to
assess the degree of cardiovascular damage
caused by air pollutants or measure the
level of risk encountered by an exposed
person."
Researchers added that previous studies
assessing the cardiovascular impact of air
pollution have taken place over longer
periods of exposure time, such as five to
six months. The current study demonstrated
that ill effects can occur more quickly, in
just five weeks.
"Further study will pinpoint critical
chemical and toxic properties of ultrafine
particles that may affect humans," Nel said.
The research team included investigators
from the fields of nanomedicine, cardiology
and genetics. Additional co-authors included
Berenice Barajas, Xuping Wang, Brian J.
Bennett and Ke Wei Gong of the David Geffen
School of Medicine at UCLA, and Jack Harkema
from the department of pathobiology and
diagnostic investigation at Michigan State
University.
Additional grant support was provided by the
National Institute of Allergy and Infectious
Diseases; the National Heart, Lung and Blood
Institute; and the Robert Wood Johnson
Foundation.